T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial. (2021)

First Author: Ewer KJ
Attributed to:  nCoV: Rapid Clinical Development of ChAdOx1 nCoV-19 funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-020-01194-5

PubMed Identifier: 33335323

Publication URI: http://europepmc.org/abstract/MED/33335323

Type: Journal Article/Review

Volume: 27

Parent Publication: Nature medicine

Issue: 2

ISSN: 1078-8956